Nakazawa Taisuke, Mori Asami, Saito Maki, Sakamoto Kenji, Nakahara Tsutomu, Ishii Kunio
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):423-30. doi: 10.1007/s00210-007-0233-z. Epub 2007 Dec 19.
Adenosine is a potent vasodilator of retinal blood vessels and is implicated to be a major regulator of retinal blood flow during metabolic stress, but little is known about the impact of diabetes on the role of adenosine in regulation of retinal hemodynamics. Therefore, we examined how diabetes affects adenosine-induced vasodilation of retinal arterioles. Male Wistar rats were treated with streptozotocin (80 mg/kg, intraperitoneally), and experiments were performed 6-8 weeks later. Rats were treated with tetrodotoxin (50 microg/kg, intravenously [i.v.]) to eliminate any nerve activity and prevent movement of the eye and infused with methoxamine continuously to maintain adequate systemic circulation. Fundus images were captured with a digital camera that was equipped with a special objective lens, and diameters of retinal arterioles were measured. Adenosine increased diameters of retinal arterioles and decreased systemic blood pressure. These responses were significantly attenuated by the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (30 mg/kg, i.v.) and the adenosine triphosphate-dependent K+ (K(ATP)) channel blocker glibenclamide (20 mg/kg, i.v.). The depressor responses to adenosine were reduced in diabetic rats, whereas diabetes did not alter vasodilation of retinal arterioles to adenosine. In contrast, both depressor response and vasodilation of retinal arteriole to acetylcholine were reduced in diabetic rats. The retinal vasodilator responses to adenosine and acetylcholine observed in diabetic rats were diminished by N(G)-nitro-L-arginine methyl ester. There were no differences in the responses to pinacidil, a K(ATP) channel opener, between the diabetic and nondiabetic rats. These results suggest that both the activation of nitric oxide synthase and opening of K(ATP) channels contribute to the vasodilator effects of adenosine in rats in vivo. However, diabetes has no significant impact on the vasodilation mediated by these mechanisms in the retinal circulation.
腺苷是视网膜血管的强效血管舒张剂,被认为是代谢应激期间视网膜血流的主要调节因子,但关于糖尿病对腺苷在视网膜血流动力学调节中作用的影响知之甚少。因此,我们研究了糖尿病如何影响腺苷诱导的视网膜小动脉血管舒张。雄性Wistar大鼠腹腔注射链脲佐菌素(80 mg/kg),6 - 8周后进行实验。大鼠静脉注射河豚毒素(50 μg/kg)以消除任何神经活动并防止眼球运动,持续输注甲氧明以维持充足的体循环。用配备特殊物镜的数码相机拍摄眼底图像,并测量视网膜小动脉的直径。腺苷增加了视网膜小动脉的直径并降低了体循环血压。这些反应被一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(30 mg/kg,静脉注射)和三磷酸腺苷依赖性钾(K(ATP))通道阻滞剂格列本脲(20 mg/kg,静脉注射)显著减弱。糖尿病大鼠对腺苷的降压反应降低,而糖尿病并未改变视网膜小动脉对腺苷的血管舒张作用。相比之下,糖尿病大鼠对乙酰胆碱的降压反应和视网膜小动脉血管舒张均降低。糖尿病大鼠中观察到的对腺苷和乙酰胆碱的视网膜血管舒张反应被N(G)-硝基-L-精氨酸甲酯减弱。糖尿病大鼠和非糖尿病大鼠对K(ATP)通道开放剂匹那地尔的反应没有差异。这些结果表明,一氧化氮合酶的激活和K(ATP)通道的开放均有助于腺苷在大鼠体内的血管舒张作用。然而,糖尿病对视网膜循环中由这些机制介导的血管舒张没有显著影响。